triple p procedure cohort study

Upload: polygone

Post on 07-Aug-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/19/2019 Triple P procedure cohort study

    1/18

    Page 1 of 18

    Triple P procedure to prevent peripartum hysterectomy inpatients with morbidly adherent placenta: a cohort study

    Poster No.: C-2445

    Congress: ECR 2013

    Type: Scientific Exhibit

    Authors: M. Teixidor Viñas, A.-M. Belli, E. Chandraharan; London/UK

    Keywords: Interventional vascular, Digital radiography, Balloon occlusion,

    Arterial access, Hemorrhage, Obstetrics

    DOI: 10.1594/ecr2013/C-2445

    Any information contained in this pdf file is automatically generated from digital material

    submitted to EPOS by third parties in the form of scientific presentations. References

    to any names, marks, products, or services of third parties or hypertext links to third-

    party sites or information are provided solely as a convenience to you and do not in

    any way constitute or imply ECR's endorsement, sponsorship or recommendation of the

    third party, information, product or service. ECR is not responsible for the content ofthese pages and does not make any representations regarding the content or accuracy

    of material in this file.

    As per copyright regulations, any unauthorised use of the material or parts thereof as

    well as commercial reproduction or multiple distribution by any traditional or electronically

    based reproduction/publication method ist strictly prohibited.

    You agree to defend, indemnify, and hold ECR harmless from and against any and all

    claims, damages, costs, and expenses, including attorneys' fees, arising from or related

    to your use of these pages.

    Please note: Links to movies, ppt slideshows and any other multimedia files are not

    available in the pdf version of presentations.www.myESR.org

  • 8/19/2019 Triple P procedure cohort study

    2/18

    Page 2 of 18

    Purpose

    Morbidly adherent placenta (MAP) is a condition which causes significant maternal

    morbidity and mortality from post partum haemorrhage. It occurs when there is invasion

    of the chorionic villi into the myometrium and its incidence is increasing[1]

    , in line with the

    increase in caesarian delivery. There are three types of MAP: Placenta percreta, increta

    and acreta. Placenta percreta is the most severebut less common.

    This is a potentially life threatening condition. It requires a radical treatment such as

    peripartum hysterectomy with or without bowel or bladder resection depending on the

    degree of infiltration of these organs[2]

    . Alternative therapies have included compression

    sutures and balloon tamponade with the placenta remaining in situ[3]

    .

    MAP can be diagnosed before delivery by ultrasound (US) and magnetic resonance

    imaging (MRI)[4]

    .

    This led us to commence a programme in 2007 of prophylactic occlusion balloon insertion

    into both internal iliac arteries before caesarian delivery in women with the most severe

    forms of morbidly adherent placenta increta and percreta.

    The purpose of the occlusion balloons is to reduce blood flow in the uterine arteries

    after caesarian delivery and so reduce blood loss, transfusion requirements and need for

    caesarian hysterectomy.

    Following the success of this programme, in July 2010 our institution developed a

    multidisciplinary procedure, called the Triple-P procedure[5]

     on page .

    The Triple-P procedure is a three step conservative treatment involving obstetricians,

    anesthetists and interventional radiologists to prevent significant haemorrhage and peri-

    partum hysterectomy. The three steps are:

    1. Perioperative location of the placenta and delivery of the fetus by an incisionabove the upper border of the placenta.

    2. Pelvic devascularisation by inflating radiologically pre-placed occlusionballoons in both internal iliac arteries.

    3. Placental non-separation with myometrial excision and reconstruction of theuterine wall.

  • 8/19/2019 Triple P procedure cohort study

    3/18

    Page 3 of 18

    The purpose is to describe a tertiary referral centre's experience with prophylactic

    balloon occlusion in women at high risk of obstetric haemorrhage from morbidly adherent

    placenta.

    Methods and Materials

    Between December 2007 and September 2012, pregnant women identified as having

    MAP by US or MRI at our institution, were defined as high risk of postpartum

    haemorrhage.

    Indications for placement of prophylactic occlusion balloons included women with the

    diagnosis of placenta percreta and increta.

    A date for caesarian delivery was planned electively.

    On the morning of delivery, an epidural catheter was inserted by the anesthetists beforethe patient was transferred to the Interventional Radiology suite for insertion of the internal

    iliac artery occlusion balloons. With informed consent, bilateral common femoral arterial

    punctures were performed under local anesthesia and occlusion balloons (7 Fr Standard

    Occlusion Balloons Catheters, Boston Scientific®) positioned contralaterally with their

    tips in the anterior divisions of each internal iliac artery under pulsed low dose fluoroscopic

    guidance to minimize radiation exposure to the mother and fetus[6]

     on page .

  • 8/19/2019 Triple P procedure cohort study

    4/18

    Page 4 of 18

    Fig. 1: Contrast injected through the catheters confirms their correct position.References:  radiology, Saint George's Hospital - London/UK

    Test occlusion was performed to ensure reduction/stasis in uterine artery blood flow and

    the volume of half strength contrast medium and normal saline solution required was

    recorded in the patient's notes and luer lock syringes with the required volume were

    attached to the catheters.

  • 8/19/2019 Triple P procedure cohort study

    5/18

    Page 5 of 18

    Fig. 2: Contralateral placement of occlusion balloon catheters into both internal iliacareries. Only fluoroscopic images are obtained.References:  radiology, Saint George's Hospital - London/UK

    The balloons were then deflated, and the catheter and the sheath flushed, stitched and

    dressed to minimize the possibility of movement during the patient's transfer.

    In the obstetric theatre a mobile image intensifier was in position so that the interventional

    radiologist could check the final position of the balloon catheter and change it if necessary

    before caesarian section commenced.

    After the baby was delivered and the umbilical cord clamped, the interventional radiologist

    was responsible for inflating each balloon to reduce blood flow whilst the obstetrician

    closed the uterus.

    If there was no evidence of haemorrhage, the balloon catheters were deflated after four

    hours and the patient observed for bleeding overnight. If the patient remained stable, the

    sheaths and occlusion balloon catheters were removed by the interventional radiologists

    the next morning.

  • 8/19/2019 Triple P procedure cohort study

    6/18

    Page 6 of 18

    If bleeding commenced, then the occlusion balloons could be rapidly re-inflated and the

    patient transferred for embolization. If significant hemorrhage occurred immediately in

    theatre, either the patient could be transferred to the IR suite or if deemed too unstable for

    transfer, the IR could proceed immediately to embolization with gelatin sponge through

    the occlusion balloon catheters.

    The following parameters were recorded for each procedure: radiographic exposure,

    volume of blood loss, transfusion requirements, uterine artery embolization, peri-partumhysterectomy, APGAR scores and any maternal complications including length of stay

    on ITU.

    Study design and participants:

    Twenty two patients were diagnosed with morbidly adherent placenta between December

    2007 and September 2012.

    • Between December 2007 and February 2010 eleven patients hadprophylactic occlusion balloon catheters placed in both anterior trunks of theIIA and an elective caesarean delivery (Group 1).

    • Between March 2010 and September 2012, eleven patients were treatedusing the Triple P procedure (Group 2).

  • 8/19/2019 Triple P procedure cohort study

    7/18

    Page 7 of 18

    Fig. 3: Distribution of study population by mode of treatment, and result.References:  radiology, Saint George's Hospital - London/UK

    All caesarean deliveries apart from one were performed electively. In all cases occlusion

    balloons were successfully placed prior to caesarian delivery.

    Statistical methods:

    Descriptive characteristics were calculated for the variables of interest. Statistic analysis

    comparing both groups has been done using the Chi-square test (Fisher's Exact Test)

    for categorical variables; and the Wilcoxon-Mann & Whitney for numerical variables.

    on page

    Images for this section:

  • 8/19/2019 Triple P procedure cohort study

    8/18

    Page 8 of 18

    Fig. 1: Contrast injected through the catheters confirms their correct position.

  • 8/19/2019 Triple P procedure cohort study

    9/18

    Page 9 of 18

    Fig. 2:  Contralateral placement of occlusion balloon catheters into both internal iliac

    areries. Only fluoroscopic images are obtained.

  • 8/19/2019 Triple P procedure cohort study

    10/18

    Page 10 of 18

    Fig. 3: Distribution of study population by mode of treatment, and result.

  • 8/19/2019 Triple P procedure cohort study

    11/18

    Page 11 of 18

    Results

    Twenty two patients were diagnosed with morbidly adherent placenta between December

    2007 and September 2012.

    • Between December 2007 and February 2010 eleven patients had

    prophylactic occlusion balloon catheters placed in both anterior trunks of theIIA and an elective caesarean delivery (Group 1).

    • Between March 2010 and September 2012, eleven patients were treatedusing the Triple P procedure (Group 2).

    All caesarean deliveries apart from one were performed electively. In all cases occlusion

    balloons were successfully placed prior to caesarian delivery.

    The clinical characteristics of the patients of both groups are summarized in Table 1.

    Table 1: The clinical characteristics of all the patients included in the study and forboth groups are summarized in the table.

  • 8/19/2019 Triple P procedure cohort study

    12/18

    Page 12 of 18

    References:  radiology, Saint George's Hospital - London/UK

    There were no significant differences between the groups for age, parity, previous

    gynaecological surgery or degree of morbidly adherent placenta.

    Fig. 4: Patients with previous gynaecological surgery distribution.References:  radiology, Saint George's Hospital - London/UK

    The mean age at study entry was 34 years old and the weeks of gestation were 34.3

    (+/-5.44). Only one woman was nulliparous in our study, and she was part of Group 1.

    A reduction in mean radiation dose between the two groups (168, 91 +/- 122,64 mGy

    in Group 1 vs 81,01 +/- 51,4 mGy in Group 2) was observed . There was no change in

    radiographic equipment.

    Mean blood loss during the surgery was 2,17 +/- 2,47 liters in Group 1 vs 1,44 +/-

    0,54 liters in Group 2, p= 0.847. Although reduced blood loss was observed in Group 2

    compared with Group 1, this was not statistically significant between the two groups.

  • 8/19/2019 Triple P procedure cohort study

    13/18

    Page 13 of 18

    Fig. 5: BLOOD LOST DURING THE PROCEDURE: The boxplots represents thesmallest and largest observation, lower and upper quartile and median of blood lostduring the procedure. Group 1 had patients outliers and the group is less uniform in

    blood lost. The graphic 1 showed than more than 50% of patients treated in Group 2bled less than the median of blood lost in Group 1.References:  radiology, Saint George's Hospital - London/UK

    There was no significant difference between the number of women requiring a transfusion

    in both groups (45.5% in Group 1 vs 54.5% in Group 2, p=0,67) although there was a

    trend to increased volume of transfused products in Group 1.

    There were 8 patients in total who required emergency embolisation for postpartum

    haemorrhage (36,4%):

    - five of them in Group 1 (45,5%)

    - 3 in Group 2 (27,3%),

    but this was not statistically significant between both groups (p=0.659).

  • 8/19/2019 Triple P procedure cohort study

    14/18

    Page 14 of 18

    Three women in Group 1 required an emergency hysterectomy (27.3%) whilst nobody in

    group 2 required hysterectomy. However the total numbers in this report are too small to

    detect a statistically significant difference.

    There were no minor or major maternal or infant complications.

    All patients were transferred to intensive care unit immediately after the delivery as perprotocol, with a mean stay of 2,82 days (+/- 2,64 days) in Group 1 and 3,44 days (+/- 1,51

    days) in Group 2. Also, there were no significant differences between the whole inpatient

    stay in both groups (p=0,603).

    COMPLICATIONS

    In one case in Group 1, rupture of the occlusion balloons occurred after caesarian section.

    The interventional radiologist was unable to attend the delivery in this case and despite

    the required volumes being written in the notes, the syringes became displaced during

    transfer and a volume ten times greater than required was injected, with consequentbilateral balloon rupture. Without the reduction in blood flow in the uterine arteries, the

    patient haemorrhaged during separation of the placenta and the obstetrician proceeded

    immediately to hysterectomy. This highlights the importance of the IR attending the

    delivery, ensuring the occlusion balloon is filled appropriately and having embolic material

    and equipment available immediately in theatre.

    In two other cases (Group 1), haemorrhage was treated by UAE but hysterectomy was

    required as haemorrhage continued.

    One patient with placenta percreta (Group 1) required a second UAE four months after

    the delivery for further haemorrhage which was successful.

    Migration of the balloon catheter was observed in two patients in Group 2. (fig. 5). Again,

    this highlights the importance of the IR attending the delivery, ensuring the occlusion

    balloon has not migrate during the patient's transfer from DSA suit to the delivery room.

    None of the major surgical complications described in the literature with caesarian

    hysterectomy were encountered eg vesicouterine fistula, bladder injury or postoperative

    abscess[7]

     on page .

    Images for this section:

  • 8/19/2019 Triple P procedure cohort study

    15/18

    Page 15 of 18

    Table 1: The clinical characteristics of all the patients included in the study and for both

    groups are summarized in the table.

  • 8/19/2019 Triple P procedure cohort study

    16/18

    Page 16 of 18

    Fig. 4: Patients with previous gynaecological surgery distribution.

  • 8/19/2019 Triple P procedure cohort study

    17/18

    Page 17 of 18

    Fig. 5: BLOOD LOST DURING THE PROCEDURE: The boxplots represents the smallest

    and largest observation, lower and upper quartile and median of blood lost during the

    procedure. Group 1 had patients outliers and the group is less uniform in blood lost. The

    graphic 1 showed than more than 50% of patients treated in Group 2 bled less than themedian of blood lost in Group 1.

  • 8/19/2019 Triple P procedure cohort study

    18/18

    Page 18 of 18

    Conclusion

    Prophylactic occlusion balloon catheter insertion in both IIA's prior to elective caesarean

    delivery in patients with MAP is useful in reducing postpartum haemorrhage, and

    decreases the risk of hysterectomy in young women with preservation of fertility. The

    Triple P procedure leads to further improvement in outcomes and is the procedure of

    choice at our institution.

    References

    [1]  Obstet Gynecol 2002; 99:976-80. The likelihood of placenta praevia with greater

    number of caesaren deliveries and high parity. Gillam M, Rosenberg D, Davis F

    [2] BJOG 2007;114:1380-1387. Knight M on behalf of UKOSS. Peripartum hysterectomy

    in the UK: management and outcomes of the associated haemorrhage.

    [3]  Acta Obstet Gynecol Scand. Sep 2010;89 (9):  1126-33. The morbidly adherent

    placenta: an overview of management options. Doumouchtsis S, Arulkumaran S.

    [4]  J Obstet Gynecol 2004; 24 (7): 742-744. Imaging techniques to identify morbidly

    adherent placenta praevia: a prospective study. Moodley J, Ngambu NF, Corr P

    [5]

      Int J Gynaecol Obstet.  2012 May;117(2):191-4. The triple- P procedure as a

    conservative surgical alternative to peripartum hysterectomy for placenta percreta.Chandraharan E; Rao S; Belli A-M; Arulkumaran S.

    [6]

      Radiographics. 2012 Jan-Feb;32(1):255-74. Interventional Radiology in Pregnancy

    Complications: Indications, Technique, and Methods for Minimizing Radiation Exposure.

    Thabet A; Kelva S; Liu B; Mueller P; Lee S.

    [7]

    Obstet Gynecol. 2004 Sep;104(3):531-6. Conservative versus extirpative management

    in cases of placenta accrete. Kayem G, Davy C, Goffinet F.

    Personal Information

    http://www.ncbi.nlm.nih.gov/pubmed?term=The%20triple-%20P%20procedure%20as%20a%20conservative%20surgical%20alternative%20to%20peripartum%20hysterectomy%20for%20placenta%20percreta.%20Chandraharan%20E%3B%20Rao%20S%3B%20Belli%20A-M%3B%20Arulkumaran%20S.%20International%20Journal%20of%20Gynacology%20and%20Obstetrics%20%282012%29http://www.ncbi.nlm.nih.gov/pubmed?term=Conservative%20versus%20extirpative%20management%20in%20cases%20of%20placenta%20accrete.%20Kayem%20G%2C%20Davy%20C%2C%20Goffinet%20F.%20Obstetric%20Gynecology%20%282004%29%20104%3B%20531-536.http://www.ncbi.nlm.nih.gov/pubmed?term=The%20triple-%20P%20procedure%20as%20a%20conservative%20surgical%20alternative%20to%20peripartum%20hysterectomy%20for%20placenta%20percreta.%20Chandraharan%20E%3B%20Rao%20S%3B%20Belli%20A-M%3B%20Arulkumaran%20S.%20International%20Journal%20of%20Gynacology%20and%20Obstetrics%20%282012%29http://onlinelibrary.wiley.com/doi/10.1111/aog.2010.89.issue-9/issuetoc